FDA PLATO deaths list challenges aspirin dose—ticagrelor interaction

FDA PLATO deaths list challenges aspirin dose—ticagrelor interaction

No abstract present.

Bibliographic Details
Main Authors:	Victor Serebruany, Jean-Francois Tanguay
Format:	Article
Language:	English
Published:	IMR (Innovative Medical Research) Press Limited 2021-09-01
Series:	Reviews in Cardiovascular Medicine
Online Access:	https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453054247-818878977.pdf

Similar Items

Misreported Cancer Deaths in PLATO Trial
by: Victor Serebruany, et al.
Published: (2021-07-01)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
by: Nikita Lomakin, et al.
Published: (2019-12-01)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
by: Hamzah Khan, et al.
Published: (2020-10-01)

Results of clinical studies PLATO and place of ticagrelor in the treatment of acute coronary syndrome
by: A. D Erlih
Published: (2015-03-01)

High-Dose, but Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells
by: Grzegorz Grześk, et al.
Published: (2013-01-01)

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
by: Kirsten Leeten, et al.
Published: (2021-10-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
by: Johny Nicolas, et al.
Published: (2020-05-01)

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial
by: Sarah Baos, et al.
Published: (2017-11-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Ticagrelor in Patients With Cancer
by: Roxana Mehran, MD, et al.
Published: (2020-06-01)

Massive Hyphaema Following Laser Iridotomy in a Patient on Dual Antiplatelet Therapy (Aspirin plus Ticagrelor): Case report and literature review
by: Virgilio Galvis, et al.
Published: (2019-05-01)

Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
by: Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Published: (2012-01-01)

Low-dose aspirin and preeclampsia prevention
by: S Wiwanitkit, et al.
Published: (2011-01-01)

The TICONC (Ticagrelor-Oncology) Study
by: Joy R. Wright, PhD, et al.
Published: (2020-06-01)

A Case of Ticagrelor Resistance
by: Jahanzeb Malik
Published: (2021-07-01)

Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting
by: Victor L. Serebruany, et al.
Published: (2017-07-01)

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study.
by: Benjamin Hibbert, et al.
Published: (2014-01-01)

Prevention of pre-eclampsia with low-dose aspirin
by: E Bujold
Published: (2011-01-01)

Metabolism of aspirin after therapeutic and toxic doses
by: Patel, Dipak Kumar Vallabhdas
Published: (1985)

Reacción de hipersensibilidad a ticagrelor
by: Jorge Alberto Castro Clavijo, et al.
Published: (2020-02-01)

Ticagrelor: clinical development and future potential
by: Nicholas C. Sanderson, et al.
Published: (2021-06-01)

Effects of ticagrelor on the pharmacokinetics of rivaroxaban in rats
by: Jia Chong, et al.
Published: (2020-01-01)

Impact of Crystal Habit on Solubility of Ticagrelor
by: Yan Ren, et al.
Published: (2019-10-01)

Ticagrelor Removal From Human Blood
by: George O. Angheloiu, MD, et al.
Published: (2017-04-01)

Southern Saskatchewan Ticagrelor Registry experience
by: Dehghani P, et al.
Published: (2014-10-01)

Ticagrelor-Induced Prolongation of the QTc Interval
by: Avik Ray, et al.
Published: (2019-01-01)

Investigation of Solubility Enhancement Approaches of Ticagrelor
by: Ihsan A. Mohammed, et al.
Published: (2018-06-01)

Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
by: Iouri Banakh, et al.
Published: (2017-01-01)

Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects
by: Qian Zhu, et al.
Published: (2019-03-01)

Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions
by: Weili Kong, et al.
Published: (2019-06-01)

R. M. Dancy, Plato’s Introduction of Forms
by: Jean-François Pradeau
Published: (2007-10-01)

Dose Selection in a Pandemic: A Framework Informed by the FDA Animal Rule
by: Kunyi Wu, et al.
Published: (2021-01-01)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
by: Lucyna Mastalerz, et al.
Published: (2021-08-01)

Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review
by: Lee YJ, et al.
Published: (2018-01-01)

Effects of low-dose aspirin on the osseointegration process in rats
by: Ana Carolina Lupepsa, et al.
Published: (2021-01-01)

Effect of different doses of aspirin on the prognosis of Kawasaki disease
by: Jinxin Wang, et al.
Published: (2020-06-01)

Effects of Low-Dose Aspirin Therapy on Thermoregulation in Firefighters
by: Serina J. McEntire, et al.
Published: (2015-09-01)

Low-dose aspirin as treatment for central serous chorioretinopathy
by: Antonio Caccavale, et al.
Published: (2010-08-01)

Low-dose aspirin therapy in IVF and ICSI patients
by: Haapsamo, M. (Mervi)
Published: (2011)